REST/NRSF (repressor-element-1-silencing transcription factor/ neuron-restrictive silencing factor) negatively regulates the transcription of genes containing RE1 sites 1,2 . REST is expressed in non-neuronal cells and stem/progenitor neuronal cells, in which it inhibits the expression of neuron-specific genes. Overexpression of REST is frequently found in human medulloblastomas and neuroblastomas [3] [4] [5] [6] [7] , in which it is thought to maintain the stem character of tumour cells. Neural stem cells forced to express REST and c-Myc fail to differentiate and give rise to tumours in the mouse cerebellum 3 . Expression of a splice variant of REST that lacks the carboxy terminus has been associated with neuronal tumours and small-cell lung carcinomas [8] [9] [10] , and a frameshift mutant (REST-FS), which is also truncated at the C terminus, has oncogenic properties 11 . Here we show, by using an unbiased screen, that REST is an interactor of the F-box protein b-TrCP.
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REST is degraded by means of the ubiquitin ligase SCF
b-TrCP during the G2 phase of the cell cycle to allow transcriptional derepression of Mad2, an essential component of the spindle assembly checkpoint. The expression in cultured cells of a stable REST mutant, which is unable to bind b-TrCP, inhibited Mad2 expression and resulted in a phenotype analogous to that observed in Mad2 1/2 cells. In particular, we observed defects that were consistent with faulty activation of the spindle checkpoint, such as shortened mitosis, premature sister-chromatid separation, chromosome bridges and mis-segregation in anaphase, tetraploidy, and faster mitotic slippage in the presence of a spindle inhibitor. An indistinguishable phenotype was observed by expressing the oncogenic REST-FS mutant 11 , which does not bind b-TrCP. Thus, SCF b-TrCP -dependent degradation of REST during G2 permits the optimal activation of the spindle checkpoint, and consequently it is required for the fidelity of mitosis. The high levels of REST or its truncated variants found in certain human tumours may contribute to cellular transformation by promoting genomic instability.
F-box proteins are the substrate-recognition subunits of SCF (SKP1-CUL1-F-box protein) ubiquitin ligases, providing specificity to ubiquitin conjugation reactions 12, 13 . Mammals express two paralogues of the F-box protein b-TrCP (b-TrCP1 and b-TrCP2) that are biochemically indistinguishable; we shall therefore use b-TrCP to refer to both, unless otherwise specified.
To identify substrates of the SCF b-TrCP ubiquitin ligase, we used an immunoaffinity/enzymatic assay followed by mass spectrometry analysis 14, 15 . In two independent purifications, peptides corresponding to REST were identified. The interaction between REST and b-TrCP suggested that SCF b-TrCP is the ubiquitin ligase targeting REST for degradation. To investigate the specificity of this binding, we screened 16 F-box proteins as well as two related proteins, CDH1 and CDC20. b-TrCP1 and b-TrCP2 were the only proteins that immunoprecipitated together with endogenous REST (Fig. 1a and data not shown). Interaction between endogenous b-TrCP1 and REST was also observed ( Supplementary Fig. 1a ).
Most proteins recognized by b-TrCP contain a DSGXXS degron in which the serine residues are phosphorylated, allowing binding to b-TrCP 16 . REST has a similar motif at the C terminus in which the first serine residue is replaced by glutamic acid, in an analogous manner to other known b-TrCP substrates ( Supplementary Fig.  2a) . Supplementary Fig. 3 shows that this sequence fits with low energy into the three-dimensional structural space of the b-TrCP substrate-binding surface, similarly to a phospho-peptide corresponding to the degron of b-catenin, a well-characterized substrate of b-TrCP 17 . We generated a number of human REST mutants (all with haemagglutinin epitope (HA) tags), in which Glu 1009 and/or Ser 1013 were mutated to Ala ( Supplementary Fig. 2b ), expressed them in HEK-293T cells, and immunoprecipitated them with anti-HA resin. Whereas wild-type REST efficiently immunoprecipitated endogenous b-TrCP1, the REST(E1009A), REST(S1013A) and REST (E1009A/S1013A) mutants did not ( Fig. 1b and Supplementary  Fig. 1b) , showing that Glu 1009 and Ser 1013 are required for binding to b-TrCP. Accordingly, in comparison with wild-type REST, the half-lives of REST mutants were increased in HEK-293T cells (Fig. 1c) .
Because SCF b-TrCP mediates the ubiquitination of several proteins in specific phases of the cell cycle 12, 15, [18] [19] [20] , we analysed the expression of REST during the cell cycle. When HeLa cells were released from a G1/S block, REST protein levels decreased in G2, at a time when the levels of cyclin A and Emi1, which are both degraded in early mitosis, were still elevated (Fig. 1d) . Similar oscillations in REST expression were observed with different synchronization methods and cell types, including HCT116, U-2OS and human diploid IMR-90 fibroblasts ( Supplementary Fig. 4a , b and data not shown). The proteasome inhibitor MG132 prevented the disappearance of REST in HeLa and HCT116 cells arrested in prometaphase by a spindle poison ( Supplementary Fig. 5a ), showing that REST degradation is mediated by the proteasome and that this degradation persists during spindle checkpoint activation. Accordingly, in contrast with wild-type REST, REST(E1009A/S1013A) is stable in prometaphase cells (Supplementary Fig. 6a, b) .
MG132-treated prometaphase cells accumulated phosphorylated REST (Supplementary Fig. 5b ). Moreover, REST, but not REST (E1009A/S1013A), immunopurified from prometaphase cells was ubiquitinated in vitro in the presence of b-TrCP (but not FBXW8) ( Fig. 1e and Supplementary Fig. 5c ). Finally, incubation with l-phosphatase completely inhibited the ubiquitination of wild-type REST (Fig. 1e) . These findings indicate that REST phosphorylation is necessary for its ubiquitination.
To further test whether b-TrCP regulates the stability of REST, we used a double-stranded RNA (dsRNA) oligonucleotide that efficiently targets both b-TrCP1 and b-TrCP2 (refs 14, 15, 18) to decrease their expression in HeLa cells. b-TrCP knockdown inhibited the G2-specific degradation of REST (Fig. 1f) . Moreover, phosphorylated REST accumulated after b-TrCP silencing ( Supplementary  Fig. 5b ).
Together, the above results demonstrate that b-TrCP-mediated degradation of REST starts in G2, and this event requires the DEGXXS degron in the REST C terminus.
Because REST is a transcriptional repressor, we proposed that its degradation in G2 might be necessary to derepress genes involved in mitosis. We therefore analysed the expression of proteins regulating mitosis and/or cell proliferation in U-2OS cells expressing either wild-type REST or REST(E1009A/S1013A). Prometaphase U-2OS cells showed higher levels of REST(E1009A/S1013A) than wild-type REST (Fig. 2a) as a result of its stabilization ( Supplementary Fig. 6a , b). Figure 1 | REST is targeted for degradation by SCF b-TrCP during G2. a, HEK-293T cells were transfected with empty vector (EV) or the indicated FLAG-tagged F-box protein constructs (FBPs). Cell extracts were immunoprecipitated (IP) with anti-FLAG resin, and immunocomplexes were probed for the indicated proteins. b, The indicated HA-tagged proteins were expressed in HEK-293T cells. Cell extracts were subjected to immunoprecipitation with anti-HA resin followed by immunoblotting. The asterisk indicates a non-specific band. WT, wild type. c, The indicated HAtagged proteins were expressed in HEK-293T. At 24 h after transfection, cells were treated with cycloheximide (CHX). Cells were collected and proteins were analysed by immunoblotting with an anti-HA antibody (left panels) to detect REST or with an anti-Cul1 antibody (right panels) to show loading normalization. d, HeLa cells were synchronized by a double-thymidine block and released into nocodazole-containing medium. Cells were collected at the indicated times, lysed and immunoblotted. e, b-TrCP-mediated REST ubiquitination is dependent on phosphorylation. HeLa cells were infected with lentiviruses expressing HA-tagged wild-type REST or HA-tagged REST(E1009/S1013A), synchronized in prometaphase and incubated with MG132 during the last 3 h before lysis. Cell extracts were immunoprecipitated with anti-HA resin. Immunoprecipitates were incubated with either l-protein phosphatase (lPPase) or enzyme buffer before ubiquitination/degradation assays (at 30 uC for the indicated times) in the presence of in vitro transcribed/translated b-TrCP. The bracket marks a ladder of bands corresponding to polyubiquitinated REST detected by immunoblotting. ex, exposure. f, HeLa cells were transfected twice with short interfering RNA (siRNA) molecules to a non-relevant mRNA (lacZ) or to b-TrCP mRNA and then synchronized and analysed as in d.
Of the 37 proteins analysed, only the levels of Mad2 were altered in cells expressing REST(E1009A/S1013A) (Fig. 2a, and data not  shown) . Lower levels of Mad2 were also observed when the stable REST mutant was expressed in IMR-90 fibroblasts ( Supplementary  Fig. 7 ) and NIH 3T3 cells (data not shown). Mad2 is a crucial component of the spindle checkpoint, inhibiting the anaphasepromoting complex to prevent sister-chromatid separation until microtubules radiating from the spindle poles have been attached to all kinetochores 21 . Northern blot analysis showed downregulation of Mad2 mRNA in REST(E1009A/S1013A)-expressing cells (Fig. 2b) . Analysis of the Mad2 genomic sequence showed several putative RE1 sites. Chromatin immunoprecipitation analysis confirmed in vivo binding of endogenous REST to the Mad2 promoter (Fig. 2c) . In addition, a human Mad2 genomic fragment containing an RE1 site (position 26-46 relative to the transcription start site), but not one containing a deletion in the RE1 site, conferred REST responsiveness to a luciferase reporter after the transient transfection of U-2OS or IMR-90 cells (Fig. 2d and Supplementary Fig. 8) . Dominant-negative , which stabilizes endogenous REST (data not shown), inhibited the activity of the Mad2 promoter-driven luciferase reporter (Fig. 2d) . Importantly, depletion of REST in G2 IMR-90 cells induced an increase in Mad2 levels (Fig. 2e) .
These results indicate that Mad2 is a direct and physiologically relevant transcriptional target of REST. Consistent with this notion, Mad2 expression (both at the mRNA and protein level) is inversely proportional to REST protein levels during the progression of cells through G2 (Supplementary Fig. 4b, c) .
Deletion of a single Mad2 allele in mouse embryonic fibroblasts or human HCT116 cancer cells results in a defective mitotic checkpoint 23 .
To study whether failure to degrade REST in G2 also affects the spindle checkpoint, we analysed HCT116 cells (which have a relatively stable karyotype) expressing HA-tagged wild-type REST or HA-tagged REST(E1009A/S1013A). As expected, wild-type REST was degraded in G2, whereas REST(E1009A/S1013A) was stable in G2 ( Supplementary Fig. 9 ). Cells expressing REST (E1009A/S1013A) showed a decreased percentage of metaphases (Fig. 3a) . Because this effect might have been due to a faster progression through metaphase, we analysed mitotic progression by time-lapse microscopy. The average time from nuclear envelope breakdown to anaphase onset was decreased in cells expressing REST(E1009A/S1013A) in comparison with control cells (Fig. 3b, c and Supplementary Fig. 10 ). Moreover, expression of the stable REST mutant increased the number of lagging chromosomes and chromosome bridges in anaphase (Fig. 4a ) and the appearance of tetraploidy (11/61 versus 0/61 in control cells), as scored in metaphase spreads from two different experiments. More than 8% of cells expressing the stable REST mutant (6/71) displayed prematurely separated sister chromatids, in contrast with 1.4% (1/71) in control cells (Fig. 4b) . Finally, cells expressing the stable REST mutant showed a decrease in the mitotic index in the presence of a spindle poison, despite the fact that they entered into mitosis with normal kinetics (Fig. 4c and Supplementary Fig. 11 ), suggesting an increased rate of mitotic slippage and adaptation to the spindle checkpoint.
These phenotypes indicate that in cells expressing the stable REST mutant, anaphase proceeds faster and in the absence of complete and accurate chromosome-microtubule attachment. Premature anaphase and chromosome aberrations are hallmarks of the defective spindle checkpoint observed in Mad2 1/2 cells 23 . We predicted that REST-FS, an oncogenic frame-shift mutant from a colon cancer cell line 11 , would be stabilized because it lacks the b-TrCP degron. Indeed, we found that REST-FS did not bind b-TrCP and was stable in G2 HCT116 cells (Supplementary Figs 1b  and 12a) . Expression of REST-FS in U-2OS cells caused a decrease in Mad2 mRNA and Mad2 protein ( Supplementary Fig. 12b, c) and a decrease in the activity of a Mad2 promoter-driven luciferase reporter (Fig. 2d) , similarly to the expression of REST(E1009A/ S1013A). Finally, the mitotic phenotypes induced by the expression of REST-FS (Figs 3b, c and 4) were indistinguishable from those caused by REST(E1009A/S1013A).
We show here that b-TrCP-mediated degradation of REST in G2 is necessary for the optimal expression of Mad2. Failure to degrade REST produces a deficient spindle checkpoint and consequent chromosome instability. REST is expressed in non-neuronal cells and stem/progenitor neural cells, in which it inhibits neuronal differentiation by blocking the expression of neuron-specific genes 2, 24 . The transition from embryonic stem cell to stem/progenitor neuronal cell requires the proteasome-mediated degradation of REST 24 . Our study suggests that REST proteolysis must be accurately controlled to avoid subjecting neuronal tissues to cancer risk. In fact, increased levels of REST resulting from overproduction and/or C-terminal truncations, as observed in human neuronal tumours [3] [4] [5] [6] [7] 10 , would both inhibit differentiation and generate chromosomal instability, two mechanisms that contribute to tumour development. Although REST has oncogenic properties in neuronal cells, the reduction of REST expression in certain non-neuronal tumours suggests a tumour suppressor role for REST and a function in the neuroendocrine phenotype in some of these lesions 11, 25 . C-terminally truncated REST variants are also observed in non-neuronal tumours [8] [9] [10] [11] . Our study suggests that these stable REST variants may contribute to cell transformation by promoting aneuploidy 26 and genetic instability in both neuronal and non-neuronal tissues.
METHODS SUMMARY
Biochemical methods. Extract preparation, immunoprecipitation and immunoblotting were as described previously 14, 15, 18 . Transient transfections and lentivirus-mediated gene transfer. HEK-293T cells were transfected by using calcium phosphate. U-2OS cells were transfected with the use of FuGENE-6 reagent (Roche). For lentivirus-mediated gene transfer, HEK-293T cells were co-transfected with pTRIP-PGK together with packaging vectors. At 48 h after transfection, virus-containing medium was collected and supplemented with 8 mg ml 21 Polybrene (Sigma). Cells were then infected with the viral supernatant for 6 h. Transcription analyses. RNA was extracted by using the RNeasy Kit (Qiagen). cDNA synthesis was performed with Superscript III (Invitrogen). Quantitative real-time PCR analysis was performed in accordance with standard procedures, using SYBR Green mix (Bio-Rad). Mad2 primer sequences were reported previously 27 . Control ARPP P0 primers sequences were 59-GCACTGGAAGTC-CAACTACTTC-39 and 59-TGAGGTCCTCCTTGGTGAACAC-39. Northern blotting was performed as described 28 . 32 P-labelled human full-length Mad2 complementary DNA was used as a probe to detect Mad2 mRNA. For luciferase assays, U-2OS cells were transfected in a 4:2:1 ratio with HA-tagged REST constructs, luciferase reporter plasmid (pGL3-Mad2) 27 and pCMV-b-galactosidase. Luciferase activity was measured with the Luciferase Reporter Assay System (Promega), and relative luciferase activities were normalized to lacZ. Chromatin immunoprecipitations. Chromatin immunoprecipitations were conducted as described previously 29 . Mad2 primer sequences were as reported previously 27 . Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) primer sequences were 59-TCCACCACCCTGTTGCTGTA-39 and 59-ACCACAGTCC-ATGCCATCAC-39.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature.
